Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

Dimethyl fumarate (DMF) is a commonly prescribed oral medication for the treatment of relapsing forms of multiple sclerosis (MS) with a wide range of hypothesized downstream mechanisms of action. Randomized clinical trials have established its clinical efficacy by using standard objective clinical m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Patient Relat Outcome Meas
Egile Nagusiak: Ozel, Osman, Vaughn, Caila B, Eckert, Svetlana P, Jakimovski, Dejan, Lizarraga, Alexis A, Weinstock-Guttman, Bianca
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6911812/
https://ncbi.nlm.nih.gov/pubmed/31849554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S168095
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak